FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint - FDA Press Releases

FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer

from Food and Drug Administration--Press Releases http://ift.tt/2Ep57D2
via IFTTT